Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 19, 2024, titled "Sun Pharmaceuticals announces approval of Winlevi in Australia".
Press Release Mar 19 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Feb 12 2024
- Press Release Jan 31 2024
- Press Release Jan 17 2024
- Press Release Nov 01 2023
- Press Release Oct 30 2023
Later from Sun Pharmaceutical Industries
- Press Release May 23 2024
- Press Release May 31 2024
- Press Release Jun 04 2024
- Press Release Jun 14 2024
- Sun Pharma - Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a Single Injection of MM-II in Patients with Painful Knee Osteoarthritis
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries